SEPTEMBER 2, 2022

Biologics Not Associated With Infectious Complications Postoperatively in IBD

Tampa, Fla.—Exposure to biologic agents within 60 days before surgery for inflammatory bowel disease is not associated with postoperative infections, surgical site infections or anastomotic leak, according to new research. The findings, presented at the 2022 annual meeting of the American Society of Colon and Rectal Surgeons (abstract SP11), suggest that biologics do not need to be held before surgery for IBD.

According to lead study author Stefan Holubar, MD, MS, the IBD surgery section